Ceftriaxone and clavulanic acid induce antiallodynia and anti-inflammatory effects in rats using the carrageenan model
- PMID: 29861639
- PMCID: PMC5968784
- DOI: 10.2147/JPR.S154661
Ceftriaxone and clavulanic acid induce antiallodynia and anti-inflammatory effects in rats using the carrageenan model
Abstract
Introduction: Ceftriaxone (CFX) and clavulanic acid (CA) are 2 β-lactam molecules widely used as antibiotics. However, several reports of their antiallodynic properties have been published in recent years. Although this effect has been considered mostly due to a GLT1 overexpression, these molecules have also been proven to induce direct immunomodulation. In this work, we determine the acute analgesic effect of CFX and CA in an inflammatory pain model and assess if their administration may induce anti-inflammatory effects.
Methods: The carrageenan (Carr) test was used as an inflammatory pain model. Both mechanical and thermal responses were analyzed after CFX and CA administration at different times. A plethysmometer was used to determine inflammation. Also, TNF-α and IL-10 serum concentrations were determined by enzyme-linked immunosorbent assay.
Results: Both CFX and CA induced a significant thermal antiallodynic effect 3 and 24 h after administration. Furthermore, CA induced a mechanical antiallodynic effect 30, 60, and 90 min after administration. Moreover, a significant anti-inflammatory effect was found for both molecules 24 h after Carr injection. Also, both CA and CFX modulated TNF-α and IL-10 serum concentrations at different times.
Conclusion: Our results provide evidence that both CFX and CA cause an analgesic effect on a Carr inflammatory pain model and that said analgesic effect differs between each β-lactam molecule. Furthermore, this effect may be related to an anti-inflammatory effect of both molecules and a direct TNF-α and IL-10 serum concentration modulation.
Keywords: TNF-α concentration; analgesic effect; antiallodynic properties; ceftriaxone; clavulanic acid; inflammatory pain; β-lactam molecules.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures




Similar articles
-
Antiallodynic Activity of Ceftriaxone and Clavulanic Acid in Acute Administration is Associated with Serum TNF-α Modulation and Activation of Dopaminergic and Opioidergic Systems.Drug Dev Res. 2017 Mar;78(2):105-115. doi: 10.1002/ddr.21381. Epub 2017 Mar 26. Drug Dev Res. 2017. PMID: 28345130
-
Antinociceptive effects of ceftriaxone in formalin-induced nociception.Drug Dev Res. 2020 Sep;81(6):728-735. doi: 10.1002/ddr.21680. Epub 2020 May 11. Drug Dev Res. 2020. PMID: 32394536
-
The β-lactam clavulanic acid mediates glutamate transport-sensitive pain relief in a rat model of neuropathic pain.Eur J Pain. 2018 Feb;22(2):282-294. doi: 10.1002/ejp.1117. Epub 2017 Oct 6. Eur J Pain. 2018. PMID: 28984398
-
Protection of blood brain barrier integrity and modulation of inflammatory mediators during treatment of pneumococcal meningitis with daptomycin or ceftriaxone.Curr Neurovasc Res. 2014;11(3):210-22. doi: 10.2174/1567202611666140520123424. Curr Neurovasc Res. 2014. PMID: 24845856
-
Anti-inflammatory and anti-hyperalgesic effects of milnacipran in inflamed rats: involvement of myeloperoxidase activity, cytokines and oxidative/nitrosative stress.Inflammopharmacology. 2020 Aug;28(4):903-913. doi: 10.1007/s10787-020-00726-2. Epub 2020 Jun 9. Inflammopharmacology. 2020. PMID: 32518981
Cited by
-
N-Acetylcysteine and Acetylsalicylic Acid Inhibit Alcohol Consumption by Different Mechanisms: Combined Protection.Front Behav Neurosci. 2020 Jul 31;14:122. doi: 10.3389/fnbeh.2020.00122. eCollection 2020. Front Behav Neurosci. 2020. PMID: 32848653 Free PMC article.
-
Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities.Front Neurosci. 2021 Apr 15;15:650785. doi: 10.3389/fnins.2021.650785. eCollection 2021. Front Neurosci. 2021. PMID: 33935636 Free PMC article. Review.
-
Molecular and Behavioral Neuroprotective Effects of Clavulanic Acid and Crocin in Haloperidol-Induced Tardive Dyskinesia in Rats.Mol Neurobiol. 2025 Apr;62(4):5156-5182. doi: 10.1007/s12035-024-04566-x. Epub 2024 Nov 9. Mol Neurobiol. 2025. PMID: 39520654
-
Clavulanic acid prevents paclitaxel-induced neuropathic pain through a systemic and central anti-inflammatory effect in mice.Neurotherapeutics. 2025 Mar;22(2):e00522. doi: 10.1016/j.neurot.2024.e00522. Epub 2025 Jan 9. Neurotherapeutics. 2025. PMID: 39794241 Free PMC article.
-
Glutamatergic systems in neuropathic pain and emerging non-opioid therapies.Pharmacol Res. 2022 Nov;185:106492. doi: 10.1016/j.phrs.2022.106492. Epub 2022 Oct 10. Pharmacol Res. 2022. PMID: 36228868 Free PMC article. Review.
References
-
- Saudagar PS, Survase SA, Singhal RS. Clavulanic acid: a review. Biotechnol Adv. 2008;26(4):335–351. - PubMed
-
- Hu Y, Li W, Lu L, et al. An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats. Pain. 2010;148(2):284–301. - PubMed
-
- Macaluso A, Bernabucci M, Trabucco A, et al. Analgesic effect of a single preoperative dose of the antibiotic ceftriaxone in humans. J Pain. 2013;14(6):604–612. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources